Basal cell nevus syndrome: A brave new world

Archives of Dermatology

Volumn 146, Issue 1, 2010, Pages 17-19

  Goldberg, Leonard H ^a   Firoz, Bahar F ^a   Weiss, Glen J ^b   Blaydorn, Lisa ^b   Jameson, Gayle ^b   Von Hoff, Daniel D ^b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO N [4 CHLORO 3 (PYRIDIN 2 YL)PHENYL] 4 (METHYLSULFONYL)BENZAMIDE; FLUOROURACIL; GDC 0449; IMIQUIMOD; PROTEIN INHIBITOR; RETINOID; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALOPECIA; ARTICLE; BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; BLEEDING; CANCER RADIOTHERAPY; CASE REPORT; CHEMOSURGERY; FACE ERYTHEMA; HUMAN; LOW LEVEL LASER THERAPY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHEDEMA; MALE; PRIORITY JOURNAL; PULSED DYE LASER; TREATMENT RESPONSE; ULCER;

BASAL CELL NEVUS SYNDROME; DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LASER THERAPY, LOW-LEVEL; MALE; MIDDLE AGED; MOHS SURGERY; SKIN NEOPLASMS;

EID: 74549125912     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.322     Document Type: Article

References (9)

1. Bath-Hextall F, Leonardi-Bee J, Somchand N, et al. Interventions for preventing non-melanoma skin cancers in high risk groups. Cochrane Database Syst Rev. 2007;17(4):CD005414.
2. Silapunt S, Alam M, Peterson S, et al. Treatment of superficial basal cell carcinoma with 595 nm pulsed-dye laser. Paper presented at: 65th Annual Meeting of the Society for Investigative Dermatology. April 28-May 1, 2004; Providence, RI.
3. GDC-0449 in treating patients with locally advanced or metastatic solid tumors. http://clinicaltrials.gov/ct2/show/NCT00607724. Accessed December 31, 2008.
4. Pontén F, Lundeberg J, Asplund A. Principles of tumor biology and pathogenesis of SCCs and BCCs. In: Bolognia JL, Jorizzo JL, Rapini RP, eds. Dermatology. London, England: Elsevier; 2008.
5. Curis announces GDC-0449 phase I clinical data presented at American Society of Clinical Oncology Annual Meeting 2008. Drugs.com Web site. http://www.drugs .com/clinical-trials/curis-announces-gdc-0449-phase-clinical- data-presented-american-society-clinical-oncology-annual-4556.html. Accessed August 20, 2009.
6. Berg D. Nevoid basal cell carcinoma syndrome. http://emedicine.medscape. com/article/1101146-overview. Accessed December 31, 2008.
7. Bale AE, Yu KP. The hedgehog pathway and basal cell carcinomas. Hum Mol Genet. 2001;10(7):757-762.
8. Nolan K. Dramatic results for cancer drug. http://www.azcentral.com/ business/articles/2008/05/28/20080528biz-cancer0526-CP.html. Accessed January 1, 2009.
9. Von Hoff D, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med. 2009;361(12):1164-1172.